Abstract:Ferritin nanocarriers have a good prospect in the treatment of cancer. Based on the specific targeting of ferritin to tumor cells, ferritin nanocarriers can deliver drugs to mouse tumor tissues by loading therapeutic drugs or modifying them on the surface of ferritin. This allows for precise treatment of tumors with fewer side effects. In conclusion, ferritin nanocarriers can provide a promising therapeutic strategy for the treatment of tumors. Background Ferritin, a ubiquitously distributed iron storage protein, can specifically target tumor cells through transferrin receptor 1. Due to its rearrangeable nanocage structure, ferritin can be loaded with anticancer drugs. Combined with amino acid modifications on the outer‐ and/or inner‐spaces of the nanocage, ferritins can be further coupled with antigens, antibodies, and nucleotide sequences. Since ferritin is naturally presented in the human body, when used in vivo, ferritin exhibits good biocompatibility, and no immunogenic response occurs. These makes ferritin an ideal nanocarrier which shows broad application prospects in cancer therapy. Methods In this study, to find articles, a search was made in PubMed with the keywords ferritin, drug delivery, drug delivery, and cancer treatment. Results According to the investigation, some studies suggest that ferritin can be loaded with drugs and targeted for delivery to tumor tissue. Therefore, ferritin nanocarriers loaded with drugs can be used in chemotherapy, photodynamic therapy (PDT), photothermal therapy (PTT) and immunotherapy. Importantly, the specific targeting of ferritin nanocarriers to tumor cells increases the effectiveness of related therapies and reduces side effects. Conclusions We conclude in this paper that the superior properties of ferritin nanocarriers as an emerging drug delivery system make them a promising cancer treatment strategy. In the future, it is worth conducting clinical trials to further investigate the safety and efficacy of ferritin nanocarriers in patients.

Re-engineering the inner surface of ferritin nanocage enables dual drug payloads for synergistic tumor therapy

Inlaying Radiosensitizer onto the Polypeptide Shell of Drug-Loaded Ferritin for Imaging and Combinational Chemo-Radiotherapy

Ferritin in cancer therapy: A pleiotropic tumoraffin nanocage‐based transport

Ferritin nanocage with intrinsically disordered proteins and affibody: A platform for tumor targeting with extended pharmacokinetics

H-Ferritin-Nanocaged Doxorubicin Nanoparticles Specifically Target And Kill Tumors With A Single-Dose Injection

Heat Sensitive E-helix Cut Ferritin Nanocages for Facile and High-Efficiency Loading of Doxorubicin.

Folic Acid-Targeted Disulfide-Based Cross-Linking Micelle for Enhanced Drug Encapsulation Stability and Site-Specific Drug Delivery Against Tumors

Synergistic Chemotherapy: Bioengineered Dual‐Targeting Protein Nanocage for Stereoscopical Loading of Synergistic Hydrophilic/Hydrophobic Drugs to Enhance Anticancer Efficacy (Adv. Funct. Mater. 29/2021)

Hydroxychloroquine loaded hollow apoferritin nanocages for cancer drug repurposing and autophagy inhibition

Mechanism Study of Thermally Induced Anti-Tumor Drug Loading to Engineered Human Heavy-Chain Ferritin Nanocages Aided by Computational Analysis

Shielding Ferritin with a Biomineralized Shell Enables Efficient Modulation of Tumor Microenvironment and Targeted Delivery of Diverse Therapeutic Agents

Tetralysine Modified H-chain Apoferritin Mediated Nucleus Delivery of Chemotherapy Drugs Synchronized with Passive Diffusion

Ferritin nanocages for early theranostics of tumors via inflammation-enhanced active targeting

Highly Stable Fluorinated Nanocarriers with Irgd for Overcoming the Stability Dilemma and Enhancing Tumor Penetration in an Orthotopic Breast Cancer

RGD-modified apoferritin nanoparticles for efficient drug delivery to tumors

Ferritin nanocages to encapsulate and deliver photosensitizers for efficient photodynamic therapy against cancer.

Ferritin‐Based Nanocomposite Hydrogel Promotes Tumor Penetration and Enhances Cancer Chemoimmunotherapy

Hydrogen-Bond-Driven Core-Crosslinked Supramolecular Micelles with pH/Thermal/Glutathione-Responsive Drug Release toward Enhanced Cancer Therapy

A Dual-Targeting Nanocarrier Based on Modified Chitosan Micelles for Tumor Imaging and Therapy

Fe3O4@carbon@zeolitic imidazolate framework-8 nanoparticles as multifunctional pH-responsive drug delivery vehicles for tumor therapy in vivo

pH/Redox/Lysozyme-Sensitive Hybrid Nanocarriers With Transformable Size for Multistage Drug Delivery